Delivery Order SPE2DB22D2006-SPE2DB25FW0CZ

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.28 firm fixed-price contract is for the delivery of Vimpat 200 mg tablets. It has an ultimate completion date of September 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award, valued at $1,229.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vimpat 150 mg tablets, a medication used to treat certain types of epilepsy. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2025. The contract is not set aside for any specific business category....
This federal contract award, valued at $3,311.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vimpat 100 mg tablets and has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $1,504.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product Vimpat 150 mg tablet 60s. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vimpat 100 mg tablets. The $1,415.46 firm fixed-price contract has an ultimate completion date of August 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,608.83, is for the delivery of Vimpat 150 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 7, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization. The contract does not have a set-aside designation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,179.55 firm fixed price contract is for the delivery of Vimpat 100 mg tablets. No set-aside requirement was specified. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vimpat 100 mg tablets. The $4,296.19 firm fixed-price delivery order has a period of performance through December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $1,103.80 firm fixed-price delivery order is for the supply of 4557217534 - Vimpat 150 mg tablets. This order does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products to federal agencies, with a significant focus on serving...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Vimpat 100 mg tablets. The $1,490.52 firm-fixed-price Delivery Order has a completion date of January 3, 2023 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for supplying a...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0CZ
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,493.45, is for the delivery of Vimpat 150 mg tablets. It is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025. The contract is not set aside and is open to competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is likely part of the company's broader support of federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/21/25, 7:42 PM